|
MMADHC expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.36989999999226E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.076300E-03 |
| Normal-vs-Stage2 |
1.007420E-01 |
| Normal-vs-Stage3 |
1.50647999999087E-05 |
| Normal-vs-Stage4 |
5.32409999975947E-07 |
| Stage1-vs-Stage2 |
7.658600E-01 |
| Stage1-vs-Stage3 |
7.957200E-03 |
| Stage1-vs-Stage4 |
7.031500E-04 |
| Stage2-vs-Stage3 |
1.544170E-01 |
| Stage2-vs-Stage4 |
5.592500E-02 |
| Stage3-vs-Stage4 |
5.563800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.97468999999506E-05 |
| Normal-vs-AfricanAmerican |
6.41590000016734E-07 |
| Normal-vs-Asian |
2.561000E-01 |
| Caucasian-vs-AfricanAmerican |
1.342100E-02 |
| Caucasian-vs-Asian |
8.918200E-01 |
| AfricanAmerican-vs-Asian |
4.241200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.55549999991678E-07 |
| Normal-vs-Female |
1.038340E-02 |
| Male-vs-Female |
4.937600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.157510E-03 |
| Normal-vs-Age(41-60Yrs) |
1.180800E-04 |
| Normal-vs-Age(61-80Yrs) |
9.81730000000347E-05 |
| Normal-vs-Age(81-100Yrs) |
1.357840E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.557220E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.525370E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.490200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.998600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.184200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.178200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.181800E-01 |
| Normal-vs-Grade 2 |
8.261800E-02 |
| Normal-vs-Grade 3 |
7.63630000011339E-07 |
| Normal-vs-Grade 4 |
6.56450005465103E-09 |
| Grade 1-vs-Grade 2 |
9.801000E-01 |
| Grade 1-vs-Grade 3 |
2.590600E-01 |
| Grade 1-vs-Grade 4 |
3.144200E-03 |
| Grade 2-vs-Grade 3 |
3.057400E-03 |
| Grade 2-vs-Grade 4 |
2.9202000000339E-06 |
| Grade 3-vs-Grade 4 |
7.855200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.855600E-01 |
| Normal-vs-ccB subtype |
9.5474739225665E-12 |
| ccA subtype-vs-ccB subtype |
8.10462807976364E-14 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.797600E-04 |
| Normal-vs-N1 |
7.904500E-03 |
| N0-vs-N1 |
1.326240E-01 |
|
|
